Cargando…

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains

Adults with sickle cell disease (SCD) are at risk for cognitive impairment, which causes significant morbidity. Guidelines support routine cognitive screening, but no screening test is validated in this population. We explored the Montreal Cognitive Assessment (MoCA) as a possible screening test in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Early, Macy L., Linton, Elizabeth, Bosch, Allison, Campbell, Timothy, Hill‐Briggs, Felicia, Pecker, Lydia H., Lance, Eboni I., Lanzkron, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Haemoglobinopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541858/ https://www.ncbi.nlm.nih.gov/pubmed/35385886 http://dx.doi.org/10.1111/bjh.18188

Ejemplares similares

Antithrombin‐III mitigates thrombin‐mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow
por: Wulftange, William J., et al.
Publicado: (2022)

Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors
por: Gaartman, Aafke E., et al.
Publicado: (2021)

Flow adhesion of whole blood to P‐selectin: a prognostic biomarker for vaso‐occlusive crisis in sickle cell disease
por: Hines, Patrick C., et al.
Publicado: (2021)

Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data
por: Malinowski, A. Kinga, et al.
Publicado: (2021)

Longitudinal assessment of adhesion to vascular cell adhesion molecule‐1 at steady state and during vaso‐occlusive crises in sickle cell disease
por: White, Jennell, et al.
Publicado: (2021)

SLN124, a GalNac‐siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron‐overload in a mouse model of β‐thalassaemia
por: Vadolas, Jim, et al.
Publicado: (2021)

Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria
por: Aliberti, Ludovica, et al.
Publicado: (2022)

Family planning needs of young adults with sickle cell disease
por: Linton, Elizabeth A., et al.
Publicado: (2023)

Developmental disorders in children born to women with sickle cell disease: A report from the Boston Birth Cohort
por: Brucato, Martha, et al.
Publicado: (2022)

Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018
por: Early, Macy L., et al.
Publicado: (2023)

Comparisons of Severe Maternal Morbidity and Other Adverse Pregnancy Outcomes in Pregnant People With Sickle Cell Disease vs Anemia
por: Early, Macy L., et al.
Publicado: (2023)

Montreal cognitive assessment reflects cognitive reserve
por: Kang, Jae Myeong, et al.
Publicado: (2018)

Montreal Cognitive Assessment of cognitive dysfunction after basal ganglia stroke
por: Ye, Baoye, et al.
Publicado: (2022)

Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients
por: Janssen, M. A. M., et al.
Publicado: (2015)

Longitudinal Measurement Properties of the Montreal Cognitive Assessment
por: Andersson, Björn, et al.
Publicado: (2021)

Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue(®) to the Montreal Cognitive Assessment
por: Rose, Amanda F, et al.
Publicado: (2021)

Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
por: Raghunath, Sudha, et al.
Publicado: (2021)

Validation of the cognitive performance scale of the interRAI‐PAC and montreal cognitive assessment
por: Ou, Jibing, et al.
Publicado: (2022)

Progestin-only contraception is first line for sickle cell disease: a comment on “Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies, and anemias.”
por: Pecker, Lydia H., et al.
Publicado: (2023)

Marijuana use and health behaviors in a US clinic sample of patients with sickle cell disease
por: Wilson, J. Deanna, et al.
Publicado: (2020)

Comparison of Montreal Cognitive Assessment and Mini-Mental State Examination in Evaluating Cognitive Domain Deficit Following Aneurysmal Subarachnoid Haemorrhage
por: Wong, George Kwok Chu, et al.
Publicado: (2013)

Knowledge of fertility and perception of fertility treatment among adults with sickle cell disease (KNOW FERTILITY)
por: Carrithers, Bria, et al.
Publicado: (2023)

Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old‐old
por: Chen, Matthew Zhixuan, et al.
Publicado: (2022)

Application and Revision of Montreal Cognitive Assessment in China's Military Retirees with Mild Cognitive Impairment
por: Zhai, Yali, et al.
Publicado: (2016)

The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment
por: van der Hoek, Marjanne D., et al.
Publicado: (2019)

Montreal Cognitive Assessment for cognitive assessment in chronic kidney disease: a systematic review
por: Amatneeks, Thaís Malucelli, et al.
Publicado: (2019)

Psychometric Properties of the Persian Montreal Cognitive Assessment in Mild Cognitive Impairment and Alzheimer Disease
por: Rashedi, Vahid, et al.
Publicado: (2021)

Montreal Cognitive Assessment for Evaluating Cognitive Impairment in Subarachnoid Hemorrhage: A Systematic Review
por: Cornea, Amalia, et al.
Publicado: (2022)

Cognitive Performance on the Montreal Cognitive Assessment Test and Retinal Structural and Functional Measures in Glaucoma
por: Bastani Viarsagh, Solmaz, et al.
Publicado: (2022)

Comparison of Alternate and Original Items on the Montreal Cognitive Assessment
por: Lebedeva, Elena, et al.
Publicado: (2016)

Concordance of the Montreal cognitive assessment with standard neuropsychological measures
por: Vogel, Sally J., et al.
Publicado: (2015)

Correction: Application and Revision of Montreal Cognitive Assessment in China's Military Retirees with Mild Cognitive Impairment
por: Zhai, Yali, et al.
Publicado: (2016)

Correlation Between Montreal Cognitive Assessment and Functional Outcome in Subacute Stroke Patients With Cognitive Dysfunction
por: Lim, Kil-Byung, et al.
Publicado: (2018)

Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson’s disease
por: Almeida, Kelson James, et al.
Publicado: (2019)

Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease
por: Jeon, Junbeom, et al.
Publicado: (2022)

Montreal Cognitive Assessment: Normative Data for Cognitively Healthy Swedish 80- to 94-Year-Olds
por: Classon, Elisabet, et al.
Publicado: (2022)

DEVELOPMENT OF A SWEDISH SHORT VERSION OF THE MONTREAL COGNITIVE ASSESSMENT FOR COGNITIVE SCREENING IN PATIENTS WITH STROKE
por: ABZHANDADZE, Tamar, et al.
Publicado: (2023)

Validity of the Montreal Cognitive Assessment (MoCA) Index Scores: a Comparison with the Cognitive Domain Scores of the Seoul Neuropsychological Screening Battery (SNSB)
por: Kim, Haeyoon, et al.
Publicado: (2021)

Investigation of Play Intervention for Dementia (PID) Activities in Addressing Cognitive Domains Reflected in Hong Kong Montreal Cognitive Assessment (HK-MoCA)
por: Lo, Calvin Ka-Fung, et al.
Publicado: (2022)

Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity
por: Milani, Sadaf Arefi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pbo9tn1qmrlhqqk9899p2csfq7